Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

By  

Oncology, Vol. 83, Iss. 3, 2012-07 ,pp. : 141-150

Karger

Access to resources Recommend Favorite

Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen

By Fleeman Nigel   Payne Katherine   Newman William G   Howell Sacha J   Boland Angela   Oyee James   Saborido Carlos Martin   Santander Ana Fernández   Dickson Rumona  

Personalized Medicine, Vol. 10, Iss. 6, 2013-08 ,pp. : 601-611

Future Medicine

Access to resources Recommend Favorite

Involving patients in the decision-making process regarding breast cancer treatment: implications for surgery utilization

By Hawley Sarah T  

Women's Health, Vol. 6, Iss. 2, 2010-03 ,pp. : 161-164

Future Medicine

Access to resources Recommend Favorite

Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer

By  

CANCER, Vol. 120, Iss. 9, 2014-05 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adding the ‘medicines’ back into personalized medicine to improve cancer treatment outcomes

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 929-931

John Wiley & Sons Inc

Access to resources Recommend Favorite